Advertisement
Australia markets closed
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • AUD/USD

    0.6516
    -0.0020 (-0.30%)
     
  • OIL

    82.43
    +1.08 (+1.33%)
     
  • GOLD

    2,226.50
    +13.80 (+0.62%)
     
  • Bitcoin AUD

    108,645.65
    +2,902.06 (+2.74%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.6026
    -0.0005 (-0.07%)
     
  • AUD/NZD

    1.0894
    +0.0014 (+0.13%)
     
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NASDAQ

    18,260.04
    -20.81 (-0.11%)
     
  • FTSE

    7,960.03
    +28.05 (+0.35%)
     
  • Dow Jones

    39,748.47
    -11.61 (-0.03%)
     
  • DAX

    18,493.72
    +16.63 (+0.09%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     

Why Analysts Remain on Sidelines for CHD and CLX

Why Analysts Remain on Sidelines for CHD and CLX

What's Ahead for Church & Dwight and Clorox?(Continued from Prior Part)Valuation a concernThe majority of analysts covering Church & Dwight (CHD) and Clorox (CLX) stock maintain a neutral outlook despite better growth prospects among peers.